Literature DB >> 10928491

Transient inhibitors in the Recombinate PUP study.

C Rothschild, J Gill, I Scharrer, G Bray.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10928491

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

1.  Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.

Authors:  R Kulkarni; R J Presley; J M Lusher; A D Shapiro; J C Gill; M Manco-Johnson; M A Koerper; T C Abshire; D DiMichele; W K Hoots; P Mathew; D J Nugent; S Geraghty; B L Evatt; J M Soucie
Journal:  Haemophilia       Date:  2016-11-04       Impact factor: 4.287

2.  The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.

Authors:  B M Reipert; B Gangadharan; C J Hofbauer; V Berg; H Schweiger; J Bowen; J Blatny; K Fijnvandraat; E S Mullins; J Klintman; C Male; C McGuinn; S L Meeks; V C Radulescu; M V Ragni; M Recht; A D Shapiro; J M Staber; H M Yaish; E Santagostino; D L Brown
Journal:  Blood Adv       Date:  2020-11-24

3.  High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance.

Authors:  Giuseppe Tagariello; Alfonso Iorio; Davide Matino; Donata Belvini; Roberta Salviato; Roberto Sartori; Paolo Radossi
Journal:  J Hematol Oncol       Date:  2013-08-30       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.